Core Scientific, Inc./tx
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
CORZ$13.13+3.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(Unaudited, in thousands)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from Operating Activities: | ||
| Net loss | $(324,368) | $(504,575) |
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||
| Depreciation and amortization | 50,133 | 54,816 |
| Loss on disposal of property, plant and equipment | 20,253 | 4,472 |
| Loss on remeasurement of assets held for sale, net | 21,013 | — |
| Impairment of property, plant and equipment | 266,488 | — |
| Change in operating lease right-of-use assets | 10,046 | 8,248 |
| Stock-based compensation | 61,186 | 70,301 |
| Digital asset self-mining revenue | (63,903) | (187,396) |
| Proceeds from sales of digital assets generated by self-mining revenue(1) | 286,765 | — |
| Gain on fair value of digital assets | (3,338) | (30,066) |
| Change in fair value of warrants and contingent value rights | 41,956 | 363,358 |
| Loss on debt extinguishment | 5,435 | 1,377 |
| Deferred income taxes | (105,816) | — |
| Accrued interest capitalized to construction in progress | (23,273) | — |
| Changes in operating assets and liabilities: | ||
| Customer funding receivable | 54,499 | (335,643) |
| Accounts payable | (82,177) | 105,615 |
| Accrued expenses | 167,124 | 244,977 |
| Deferred revenue from colocation services | 19,151 | 323,796 |
| Other current assets | (50,979) | 11,500 |
| Other operating assets and liabilities, net | (53,952) | (10,040) |
| Net cash provided by operating activities | 296,243 | 120,740 |
| Cash flows from Investing Activities: | ||
| Purchases of property, plant and equipment | (1,494,979) | (449,752) |
| Proceeds from sales of property, plant and equipment | 6,094 | 1,929 |
| Cash paid for asset acquisitions | (676,881) | — |
| Other investing activities | (149) | (15,160) |
| Net cash used in investing activities | (2,165,915) | (462,983) |
| Cash flows from Financing Activities: | ||
| Debt extinguishment payments | (1,000,000) | (26,862) |
| Proceeds from the issuance of debt | 4,275,250 | — |
| Debt issuance costs | (50,907) | — |
| Taxes paid related to net share settlement of equity awards | (35,152) | (5,893) |
| Principal payments on debt | — | (8,613) |
| Proceeds from exercise of warrants | 11,742 | 1,746 |
| Other financing activities | (1,095) | (1,672) |
| Net cash provided by (used in) financing activities | 3,199,838 | (41,294) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 1,330,166 | (383,537) |
| Cash, cash equivalents and restricted cash—beginning of period | 311,378 | 836,980 |
| Cash, cash equivalents and restricted cash—end of period | $1,641,544 | $453,443 |
| Supplemental disclosures of other cash flow information: | ||
| Cash paid for interest, net of capitalized interest | $19,313 | $15,285 |
| Income tax payments | $640 | $298 |
| Supplemental disclosures of non-cash investing and financing activities: | ||
|---|---|---|
| Purchases of property, plant and equipment in accounts payable and accrued expenses | $429,937 | $154,440 |
| Reclass of property, plant and equipment to held for sale | $51,262 | $— |
| Operating lease right-of-use assets obtained in exchange for lease obligations | $13,440 | $2,154 |
| Non-cash exercise of warrants | $1,514 | $24,692 |
| Liabilities assumed in acquisition | $115,790 | $— |
| Issuance of warrants | $296,423 | $— |
| Interest capitalized to construction in progress | $25,828 | $— |
| Reconciliation of cash, cash equivalents and restricted cash within the Condensed Consolidated Balance Sheets to the amounts shown in the Condensed Consolidated Statements of Cash Flows above: | ||
| Cash and cash equivalents | $803,941 | $453,443 |
| Restricted cash, current portion | 201,745 | — |
| Restricted cash, net of current portion | 635,858 | — |
| Total cash, cash equivalents and restricted cash | $1,641,544 | $453,443 |
(1)Proceeds from digital assets received as non-cash revenue consideration liquidated at management's discretion.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.